These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15801127)

  • 1. Proceedings of the First International Society of Chemotherapy International Conference on Cancer Therapeutics-Molecular Targets, Pharmacology and Clinical Applications. February, 19-21, 2004. Florence, Italy.
    J Chemother; 2004 Nov; 16 Suppl 4():3-116. PubMed ID: 15801127
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer Therapeutics, Molecular Targets, Pharmacology and Clinical Applications--First International Conference 19-21 February 2004, Florence, Italy.
    Roberts J
    IDrugs; 2004 Apr; 7(4):301-5. PubMed ID: 15057630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer trial assesses clinical benefit of gene-targeted treatment.
    Katsnelson A
    Nat Biotechnol; 2014 Apr; 32(4):306. PubMed ID: 24714466
    [No Abstract]   [Full Text] [Related]  

  • 4. New targets and innovative strategies in cancer treatment: a short course for clinicians. 7-8 February 2003, Monte Carlo, Monaco.
    Eskens F
    IDrugs; 2003 Mar; 6(3):207-10. PubMed ID: 12838991
    [No Abstract]   [Full Text] [Related]  

  • 5. G-quadruplexes: selective DNA targeting for cancer therapeutics?
    Miller KM; Rodriguez R
    Expert Rev Clin Pharmacol; 2011 Mar; 4(2):139-42. PubMed ID: 22115396
    [No Abstract]   [Full Text] [Related]  

  • 6. CNIO cancer conference: targeted search for anticancer drugs.
    Fischer PM
    Expert Opin Investig Drugs; 2003 Jun; 12(6):1039-44. PubMed ID: 12783608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in cancer chemotherapy. Proceedings of a symposium held in conjunction with the 6th European Conference on Clinical Oncology. Florence, Italy, October 29, 1991.
    Ann Oncol; 1992 Aug; 3 Suppl 3():1-67. PubMed ID: 1356416
    [No Abstract]   [Full Text] [Related]  

  • 8. AACR-NCI-EORTC--21st International Symposium. Molecular targets and cancer therapeutics--Part 2.
    Walker K; Padhiar M
    IDrugs; 2010 Jan; 13(1):10-2. PubMed ID: 20024839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoscale delivery systems for multiple drug combinations in cancer.
    Cao Y; Wang B; Lou D; Wang Y; Hao S; Zhang L
    Future Oncol; 2011 Nov; 7(11):1347-57. PubMed ID: 22044207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abstracts of the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics: Discovery, Biology, and Clinical Applications. October 22-26, 2007. San Francisco, California, USA.
    Mol Cancer Ther; 2007 Dec; 6(12 Pt 2):3331s-704s. PubMed ID: 18300399
    [No Abstract]   [Full Text] [Related]  

  • 11. AACR-NCI-EORTC International Conference 2009.
    Awada A; Lacombe D
    Expert Rev Anticancer Ther; 2010 Mar; 10(3):319-20. PubMed ID: 20214512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-penetrating peptides: strategies for anticancer treatment.
    Raucher D; Ryu JS
    Trends Mol Med; 2015 Sep; 21(9):560-70. PubMed ID: 26186888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New cancer therapeutics: target-specific in, cytotoxics out?
    Broxterman HJ; Georgopapadakou NH
    Drug Resist Updat; 2004 Apr; 7(2):79-87. PubMed ID: 15158764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomics, Signaling and Tumor Targeting--Sidney Kimmel Cancer Center Inaugural Conference. 16-18 February 2004, San Diego, CA, USA.
    Leoni L; Niemeyer C; Bendall H
    IDrugs; 2004 Apr; 7(4):312-4. PubMed ID: 15057632
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug self-delivery systems for cancer therapy.
    Qin SY; Zhang AQ; Cheng SX; Rong L; Zhang XZ
    Biomaterials; 2017 Jan; 112():234-247. PubMed ID: 27768976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New chemical adaptor unit designed to release a drug from a tumor targeting device by enzymatic triggering.
    Gopin A; Rader C; Shabat D
    Bioorg Med Chem; 2004 Apr; 12(8):1853-8. PubMed ID: 15051054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AACR-NCI-EORTC--21st International Symposium. Molecular targets and cancer therapeutics--Part 1.
    Walker K; Padhiar M
    IDrugs; 2010 Jan; 13(1):7-9. PubMed ID: 20024838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful anti-cancer drug targets able to pass FDA review demonstrate the identifiable signature distinct from the signatures of random genes and initially proposed targets.
    Mayburd AL; Golovchikova I; Mulshine JL
    Bioinformatics; 2008 Feb; 24(3):389-95. PubMed ID: 17925305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virus-like nanoparticles: emerging tools for targeted cancer diagnostics and therapeutics.
    Sainsbury F
    Ther Deliv; 2017 Dec; 8(12):1019-1021. PubMed ID: 29125065
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug targeting and tumor heterogeneity.
    Bae YH
    J Control Release; 2009 Jan; 133(1):2-3. PubMed ID: 18848589
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.